Header Logo

Connection

Kriti Mittal to Bevacizumab

Back to Details
This is a "connection" page, showing publications Kriti Mittal has written about Bevacizumab.
Kriti Mittal
Connection Strength
0.109
Bevacizumab
  1. Mittal K, Koon H, Elson P, Triozzi P, Dowlati A, Chen H, Borden EC, Rini BI. Dual VEGF/VEGFR inhibition in advanced solid malignancies: clinical effects and pharmacodynamic biomarkers. Cancer Biol Ther. 2014 Aug; 15(8):975-81.
    View in: PubMed
    Score: 0.109
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.